BRIEF-Adamis Pharmaceuticals Changes Name To DMK Pharmaceuticals

Reuters2023-09-08

Sept 7 (Reuters) - Adamis Pharmaceuticals Corp :

* ADAMIS PHARMACEUTICALS CHANGES NAME TO DMK PHARMACEUTICALS TO REFLECT NEW STRATEGIC FOCUS

* ADAMIS PHARMACEUTICALS CORP - COMPANY'S COMMON STOCK IS EXPECTED TO TRADE UNDER NEW NASDAQ TICKER SYMBOL "DMK" ON OR ABOUT SEPTEMBER 8

* ADAMIS PHARMACEUTICALS CORP - DPI-125 WILL BE OUR CORE FOCUS

* ADAMIS PHARMACEUTICALS CORP - DMK EXPECTS SEVERAL POTENTIAL SIGNIFICANT MILESTONES FOR DPI-125 BY END OF 2024

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment